Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148,275,293
-
Total 13F shares
-
10,412,527
-
Share change
-
-63,275
-
Total reported value
-
$207,490,000
-
Price per share
-
$19.93
-
Number of holders
-
36
-
Value change
-
-$1,581,240
-
Number of buys
-
24
-
Number of sells
-
9
Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q2 2020
As of 30 Jun 2020 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) had 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,412,527 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, EVENTIDE ASSET MANAGEMENT, LLC, VR Adviser, LLC, Logos Global Management LP, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, and NORTHERN TRUST CORP.
This table shows 36 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.